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Manually curated genome-scale 
reconstruction of the metabolic 
network of Bacillus megaterium 
DSM319
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& Sayed-Amir Marashi  5*
Bacillus megaterium is a microorganism widely used in industrial biotechnology for production of 
enzymes and recombinant proteins, as well as in bioleaching processes. precise understanding of its 
metabolism is essential for designing engineering strategies to further optimize B. megaterium for 
biotechnology applications. Here, we present a genome-scale metabolic model for B. megaterium 
DSM319, iJA1121, which is a result of a metabolic network reconciliation process. The model includes 
1709 reactions, 1349 metabolites, and 1121 genes. Based on multiple-genome alignments and available 
genome-scale metabolic models for other Bacillus species, we constructed a draft network using an 
automated approach followed by manual curation. The refinements were performed using a gap-filling 
process. constraint-based modeling was used to scrutinize network features. phenotyping assays were 
performed in order to validate the growth behavior of the model using different substrates. To verify 
the model accuracy, experimental data reported in the literature (growth behavior patterns, metabolite 
production capabilities, metabolic flux analysis using 13C glucose and formaldehyde inhibitory effect) 
were confronted with model predictions. this indicated a very good agreement between in silico results 
and experimental data. for example, our in silico study of fatty acid biosynthesis and lipid accumulation 
in B. megaterium highlighted the importance of adopting appropriate carbon sources for fermentation 
purposes. We conclude that the genome-scale metabolic model iJA1121 represents a useful tool for 
systems analysis and furthers our understanding of the metabolism of B. megaterium.
In recent decades, research on Bacillus megaterium has gained momentum due to its versatile metabolic capa-
bilities and physical properties favorable to biotechnology applications. This bacterium had already been com-
monly used in biochemical studies before the extensive popularity of Bacillus subtilis1,2. Large cell size and special 
physiochemical properties were the main incentives to use B. megaterium as a model to study cell structure, 
sporulation, and protein localization3,4. As a Gram-positive bacterium with an aerobic sporulation behavior, B. 
megaterium inhabits diverse environments, ranging from dried food to soil5. Its ability to grow on a variety of 
carbon sources has made it amenable for industrial applications6. Numerous strains of B. megaterium have been 
applied for production of various enzymes, such as penicillin amidase, amylase, amino acid dehydrogenase, and 
glucose dehydrogenase, as well as for production of recombinant proteins7–11. Moreover, it has been used as an 
alternative microorganism for production of vitamin B12, pyruvate, and shikimate12–14. Remarkably, B. mega-
terium can also be utilized as a cyanogenic bacterium in the bioleaching process, in order to mobilize precious 
metals from e-wastes15.
Among various strains of B. megaterium, B. megaterium DSM319 (B. m. DSM319 hereafter) stands out as 
being extensively investigated. B. m. DSM319 and its available derivatives are commonly used for production of 
recombinant proteins16–18 and metabolites19–22. The whole genome of B. m. DSM319 was sequenced by Eppinger 
et al.23, which provided a wealth of information on its genotype-phenotype relationships. However, genome data 
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alone was not sufficient for providing a holistic and comprehensive picture of the B. m. DSM319 metabolism. 
Therefore, there remains a knowledge gap that needs to be filled.
Genome-scale metabolic networks together with constraint-based modeling provide a computational frame-
work that can predict physiological features of cells and organisms24. Genome-scale metabolic models (GEMs) 
are used to evaluate and determine the potential of industrial strains and explore their unknown metabolic capa-
bilities25. GEM-based predictions can be used for amelioration of culture medium composition, by identifying 
key metabolites that need to be added to increase the growth rate. They can also be used for predicting metabolite 
production fluxes26 and defining gene deletion strategies for metabolic engineering27.
A GEM for B. megaterium WSH002 (B. m. WSH002 hereafter), iMZ1055, has been previously reported28. 
This model included some obsolete annotations and was shown not to be very successful in predicting fluxes29. In 
this study, a GEM has been developed for B. m. DSM319. This model reconciles iMZ1055 and biochemical data 
specific to B. m. DSM319, taking into account other Bacillus metabolic models (including iBsu1103 and iBsu1147 
for B. subtilis, and iWX1009 for B. licheniformis). Fig. 1 schematically represents the procedure of GEM recon-
struction for B. m. DSM319. It should be emphasized that our model was able to accurately predict the metabolic 
functions and growth behavior of the strain. Model predictions were in agreement with the growth simulation 
results from Biolog phenotyping assays, as well as with several experimental data-sets reported in the literature.
Results and Discussion
Genome-scale reconstruction process. According to a reconciliation process, we used genome 
sequences of Bacillus species to identify potential reactions that should be present in the GEM of B. m. DSM319. 
Genome-wide multiple sequence alignment was performed prior to refinement and validation, in order to find 
orthologs. The detected homologous gene pairs were applied as references for identification of similar gene-pro-
tein-reaction (GPRs) associations to reconstruct the draft network. For this purpose, the homologous gene pairs 
of B. m. DSM319 and B. m. WSH002 were initially identified using Mauve30. Based on the results, 4526 cod-
ing sequence (CDS) homologous pairs were determined, which will be referred to as the “COM” genes (see 
Supplementary Information). Moreover, B. m. DSM319 had 692 CDSs with no obvious homolog in the B. m. 
Figure 1. Schematic representation of the genome-scale metabolic network reconstruction procedure. Using 
Mauve, homologous gene pairs were detected to identify the reactions with similar gene-reaction associations in 
genome-scale metabolic models of Bacillus species. After the comprehensive manual curation, the draft model 
was validated and refined using phenotyping experiments and the experimental data reported in the literature.
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WSH002 genome. This set of genes will be called “BMD” genes (Fig. 2a). Those genes which are present in B. 
m. WSH002, but not in the B. m. DSM319 genome, will be called “BMW” genes. Further information about the 
reconstruction process is presented in Supplementary Information.
In the next step, the draft network was manually curated in order to find potential errors. Altogether, we 
resolved 314 errors, including the modification of GPR associations, EC numbers, metabolites, addition of several 
complex enzymes and isozymes, as well as modification of the relationships among genes using Boolean logical 
operators.
In order to find any potential missing reactions which are present in the other four Bacillus GEMs, we carried 
out a genome-wide multiple sequence alignment for B. megaterium, B. subtilis, and B. licheniformis. Based on the 
results (Fig. 2), 358 reactions were added to the draft network. Furthermore, the BMD genes, which are present 
in B. m. DSM319 only, together with their associated reactions which were obtained by KEGG API31, were added 
to the draft network.
Finally, the manual refinement step in the reconstruction of the B. m. DSM319 network was performed by 
examining the inconsistencies between the in silico predictions and experimental results (Biolog phenotyping 
and literature). Figure 2b schematically represents the entire process of GEM reconstruction for B. m. DSM319.
phenotyping assays. We performed Biolog phenotyping experiments to examine the capability of the draft 
network to predict growth behavior on different carbon sources. B. m. DSM319 was found to be capable of grow-
ing on 49 out of 69 different carbon sources based on triplicate independent experiments (Fig. 3). Growth on 
different carbon sources was simulated, as explained in the Materials and Methods section, using FBA32. Further 
refinements of the draft network were performed based on the observed phenotyping results and in silico predic-
tions. For every carbon source, an independent simulation was run. Among 69 different carbon sources, 60 car-
bon sources matched transport reactions while nine were known as intracellular metabolites, with no transport 
reaction in the draft model. Therefore, in order to determine potential membrane transporters for the 9 suspected 
Figure 2. Schematic representation of the reconstruction process used for the genome-scale metabolic network 
of Bacillus megaterium DSM319. (a) Based on genome alignment, 734 reactions of iMZ1055 were included in 
the reconstruction of the initial draft network. (b) The initial draft network was modified by performing several 
manual curation steps, utilization of Bacillus species GenBank genomes for multiple-alignment and further 
addition of relevant reactions to the model, and refining the model based on phenotyping data. Solid arrows 
represent the process direction and dotted lines relate to the operations that were performed based on the 
available data in public databases. “167 Reactions”, “174 Reactions” and “358 Reactions” refer to “the reactions 
that had at least one associated gene in COM and at least one associated gene in BMW”, “the reactions that were 
associated with some gene(s) of COM” and “the similar reactions that were present in the other four Bacillus 
GEMs”, respectively (see Supplementary Information).
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intracellular metabolites, a literature review was performed seeking any reported gene-protein associations for the 
missing 9 membrane transporters. The result was used for homology searches in B. m. DSM319. Thus, we iden-
tified genes encoding uncharacterized membrane proteins responsible for transport of l-pyroglutamic acid (PA) 
and d-salicin metabolites, and added the relevant transport reactions to the model. For the other 7 intracellular 
metabolites, interim hypothetical transport reactions were correspondingly added to the model. A hypothetical 
transport reaction was preserved in the model only when simulating growth on the particular corresponding 
carbon source. The addition of those hypothetical transport reactions improved model accuracy in all 7 cases. 
Our results indicated that 56 out of 69 in silico predictions for growth on different carbon sources were compatible 
with phenotyping assays. Overall, 14 discrepancies were fixed by changing reaction reversibility or filling the gaps 
based on literature mining (see Table S1 in Supplementary Information). For example, in silico simulations were 
initially not able to correctly predict the capability of B. m. DSM319 to metabolize PA. In the draft network, PA 
had been considered as an intracellular metabolite. Our investigations showed that there was a need to add the 
pyroglutamase (ATP-hydrolyzing) reaction encoded by BMD_2469. Also, it was reported that the uncharacter-
ized membrane proteins DUF969 and DUF979 are involved in PA transport in B. subtilis33,34. Based on the protein 
homology search, we decided to add a transport reaction and assumed that it is encoded by BMD_1100 and 
BMD_1101. The addition of these two reactions resulted in the model becoming capable of accurately predicting 
growth on PA as the sole carbon source. By refining and filling in the gaps, the GEM, which will be referred to as 
iJA1121, reached almost 96% accuracy in predicting substrate utilization (see Supplementary Information for the 
model in SBML format). It should be noted that iJA1121 was checked using Memote35.
By comparison, out of 69 different carbon sources, iMZ1055, the previous GEM for another strain of B. 
megaterium, predicted growth for only 38 carbon components, where 21 predictions were not consistent with 
the phenotyping experimental data. Overall, iMZ1055 could estimate growth for about 70% of carbon sources. 
Although this outcome could be attributed to metabolic differences between strains and their ability to grow 
on different carbon sources, it might in part be due to possible deficiencies within iMZ1055. A large number 
of non-growth/growth (in silico/in vivo) predictions (Fig. 3) demonstrates that some cellular functions were 
neglected in iMZ1055. It seems that there might exist other parallel metabolic pathways and isozymes that were 
not taken into account in iMZ1055.
constraint-based metabolic model of B. m. DSM319 and its performance in predicting meta-
bolic behavior. The final GEM of B. m. DSM319, iJA1121, includes 1121 genes, 1349 metabolites, and 1709 
reactions. Table 1 presents an overall comparison of GEMs available for Bacillus species. Compared to iMZ1055, 
i.e., the previous B. megaterium model, iJA1121 includes an increased number of metabolites, reactions, and 
genes.
We inspected the differences between iJA1121 and iMZ1055, in order to better understand the different meta-
bolic capabilities of the two B. megaterium strains. The results of this study are summarized in Fig. 4. We classified 
the reactions into 7 categories based on their metabolic subsystems. In all the metabolic subsystems, the number 
of reactions in iJA1121 is larger than in iMZ1055. The largest difference is observed for the fatty acid and lipid 
subsystem, where the number of reactions is approximately six-fold higher in iJA1121. In iMZ1055, teichoic acids 
and fatty acids were presented as lumped reactions with lumped species. However, iJA1121 explicitly takes into 
account the reactions producing fatty acids and lipids. In most other metabolic subsystems, the situation was 
similar. Specifically, iJA1121 includes more reactions for cell wall and capsule synthesis, metabolism of amino 
acids, carbohydrates, cofactors, and vitamins. This considerable difference in the number of reactions prompted 
us to perform an in-depth investigation of the type of differences between the two models. All the reactions in 
iJA1121 were categorized into three classes, based on how they were added to the GEM (Fig. 4b): “No-change” 
Figure 3. Results of in silico and phenotyping experiments based on growth on 69 different carbon sources (☑: 
Growth/True, ☒: No-Growth/False). The experimental results were obtained for Bacillus megaterium DSM319 
based on the procedure given in the Materials and Methods.
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refers to those reactions that remained unchanged, i.e., were added directly from iMZ1055 based on homology. 
“Changed” represents those reactions added from iMZ1055 based on homology, but with alterations in their 
GPR associations, EC numbers and/or reversibility-type. Finally, “New” refers to those reactions which were 
newly added during the reconstruction process. Accordingly, 42% of the reactions in iJA1121 are added directly 
Model iJA1121 iMZ1055 iBsu1147 iBsu1103 Oh et al., 2007 iWX1009
Species name B. m. DSM319
B. m. 
WSH002 B. s. 168 B. s. 168 B. s. 168 B. l. WX02
Reactions 1709 1112 1742 1443 1020 1762
Metabolites 1349 993 1456 1145 988 1141
Genes 1121 1055 1147 1103 844 1009
Transport reactions 190 196 290 205 232 176
Refs. This study 28 58 59 70 60
Table 1. Bacillus species genome-scale metabolic models overview.
Figure 4. Features of iJA1121, (a) distribution of iJA1121 and iMZ1055 reactions in different subsystems, (b) 
classification of reactions in iJA1121 based on the modifications, (c) modifications made to the draft network 
ranked in different subsystems. “No-change” refers to those reactions that were added directly from iMZ1055 
based on homology. “Changed” represents those reactions that were added from iMZ1055 based on homology, 
but with alterations in their GPR associations, EC numbers and/or reversibility-type. “New” refers to those 
reactions which were newly added during the reconstruction process.
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(“No-change”), based on the information in biochemical databases and literature. Among the alterations that 
were made for the reactions in the “Changed” group that comprised 26% of the reactions, the changes of GPR 
associations were the most common. This is presumably due to the automatic annotation of genes by the mod-
elSEED pipeline28. In addition, some of the EC numbers of iMZ1055 were obsolete, i.e. they were removed in 
the most recent release of the KEGG database. The other 32% of the reactions were those that were not included 
in iMZ1055. Fig. 4c shows how the changes are distributed over each of the metabolic subsystems. As expected, 
subsystems with more ambiguity in biochemical databases bore more changes36. From Fig. 4c, it can be observed 
that fatty acid and lipid, as well as cell wall and capsule subsystems have the highest ratio of added reactions. 
Also, amino acid metabolism, carbohydrate metabolism, metabolism of cofactor and vitamins, and nucleotide 
metabolism subsystems contained a large number of changes. These changes were based on the up-to-date infor-
mation in biochemical databases and the literature data, and resulted in addition of new reactions and alterations 
of several EC numbers and GPR associations. On the other hand, fewest changes in terms of the newly added 
reactions occurred in the energy metabolism subsystem. In this subsystem, most changes were related to reaction 
parameters, including some EC numbers and some GPR associations.
Prediction of growth for DSM319 and its derivatives. We characterized the growth behavior of B. m. 
DSM319, as well as that of its derivatives, namely B. m. MS941 (∆nprM), B. m. WH320 (∆lacZ) and B. m. WH323 
(XylA1-spoVG-lacZ) (Table 2)37. All strains were cultivated in M9 medium with glucose as the sole carbon source, 
under aerobic chemostat conditions. Using FBA, the growth rates were calculated for the mentioned conditions. 
Mutations in the derivative strains were reported not have a remarkable influence on glucose-based growth37,38. 
To simulate the growth of B. m. DSM319 in the M9 medium, the lower boundary for all exchange reactions, 
except those related to the metabolites in the M9 medium, was set to zero. There was a significant correlation 
between the simulation results and the experimental data (Fig. 5); indicating an acceptable agreement between 
the two (Pearson R = 0.99, p-value = 1.2 × 10−05).
Further investigation of the growth behavior of B. megaterium mutants was carried out by applying the results 
reported by Wang et al.16 to the analysis of MS941 and WH320 strains under high cell density conditions. To 
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vglc, μ, Cglc, x and Δt are glucose uptake rate, specific growth rate, glucose concentration, biomass concentration 
and time period, respectively. Subscript i refers to the time step.
We simulated these conditions by running FBA in the minimal medium and allowing glucose to enter the 
system at the flux obtained by Eq. (1). Simulations were performed under the assumption that both strains have 
similar growth behavior16. There was a good agreement between the biomass flux rates derived from simulations 
and the growth rate values (Fig. 6) (Pearson R = 0.994, p-value = 10−04).
Specific growth rate Unit DSM319 MS941 WH320 WH323
1/h 0.106 0.11 0.426 0.096 0.107
Glucose uptake rate mmol/gBM/h 1.52 1.62 5.17 1.31 1.53
Acetate uptake rate mmol/gBM/h 0.15 0.17 0.6 0.17 0.16
Table 2. Simulation conditions for different B. m. DSM319 strains.
Figure 5. Results of growth simulations under different glucose uptake fluxes. The linear equation intercept is 
forced to zero (Pearson R = 0.99, p-value = 1.2e-05).
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Simulation of aroK mutant and shikimic acid production. Limited availability and high price of pre-
cursors like shikimic acid and quinic acid is the main restraining factor for industrial production of essential 
aromatic compounds40. As a prominent compound in the pharmaceutical industry, shikimic acid is the main 
precursor for the synthesis of oseltamivir14. It is reported that a ∆aroK mutant of B. megaterium can promote 
shikimate production41. The aroK gene encodes shikimate kinase, which catalyzes the bioconversion of shikimate 
to shikimate-3-phosphate in an ATP-dependent phosphorylation reaction.
We simulated the ∆aroK by setting the lower and upper bounds of the associated reaction to zero. Then, we 
analyzed the effect of different carbon sources on the growth behavior of the mutant strain by setting the lower 
bounds of the medium components and the carbon source to −1000 and −5 mmol/gBM/h, respectively. There 
was a significant correlation (R = 0.63, p-value < 0.05 in the Pearson correlation test) between biomass flux rate 
predictions by the GEM and the dry weight cell experiments (Fig. 7). When maltose was used as the sole car-
bon source, the experimental data and the simulation result were not in agreement. Excluding maltose from 
the results improved the correlation (R = 0.946, p-value < 0.05 in the Pearson correlation test). This observation 
suggests that the reactions for assimilation of maltose in the GEM need to be improved.
Further simulations were performed to model the impact of different carbon sources on the growth rate of 
∆aroK strain (Fig. 8). By employing the experimental data reported in the literature41 and also applying Eqs. (1) 
and (2), we ran 43 FBA simulations under the aforementioned conditions. For each simulation, the lower bound 
of one carbon source was set based on the value obtained by Eq. (1). Then, FBA was performed to find the optimal 
growth rate. In the following step, we assumed the growth rate to be ≥90% of its maximum value (obtained in 
the former simulation), and another FBA was performed by taking the flux through shikimate dehydrogenase 
reaction as the objective function.
As demonstrated in Fig. 8b, this analysis yielded a significant Pearson correlation between predicted growth 
rate and the experimental cell dry weights. Pearson correlation coefficients for all substrates were higher than 
0.85. Fructose, glucose, and lactose had the highest Pearson correlation coefficients. These findings confirm the 
ability of iJA1121 to predict mutant growth behavior.
We also investigated the potential of the model for predicting shikimic acid production by the ∆aroK mutant. 
From Fig. 8c, one can observe that in silico shikimic acid production rates are reasonably consistent with the 
experimental data (for more information see Fig. S1 in Supplementary Information). For starch, maltose, and 
lactose, the highest Pearson correlation coefficients were observed, ranging from 0.98 to 0.71, while for glucose 
the smallest Pearson correlation coefficient, 0.37, was observed. However, the model failed to predict the shikimic 
acid production when sucrose was used as the sole carbon source. This can be attributed to different possible rea-
sons. Sucrose has been reported to influence gene expression as a signal molecule in some microorganisms42,43. 
Figure 6. Comparison of biomass production flux obtained by FBA and experimental growth rate values. The 
linear equation intercept is forced to zero (Pearson R = 0.994, p-value = 1e-4).
Figure 7. Comparison of biomass rate obtained by FBA and biomass dry cell experiments reported in the 
literature for different carbon sources including fructose, sucrose, lactose, glucose, starch, and maltose.
8Scientific RepoRtS |         (2019) 9:18762  | https://doi.org/10.1038/s41598-019-55041-w
www.nature.com/scientificreportswww.nature.com/scientificreports/
Also, differences in the metabolism of strains or possible errors in the reported experimental data could be other 
potential reasons for this discrepancy. These need further investigation.
Formaldehyde inhibitory effect on growth. Formaldehyde (CH2O) is a prominent disinfectant that 
hinders microbial growth, particularly for Bacillus species, e.g., B. megaterium and B. subtilis44. It was shown that 
the GEMs generated for Bacillus species are incapable of predicting growth behavior under these conditions29. 
Herein, we simulated the glucose/formaldehyde co-metabolism using FBA for growth in minimal medium and 
glucose as the carbon source. For the formaldehyde uptake simulation, an exchange reaction was added to the 
model. In order to investigate the effect of formaldehyde addition, its flux was raised in a step-wise manner, and 
a number of FBAs were performed. The same simulations were run for the previous GEMs for B. megaterium 
(iMZ1055) and B. subtilis (iBsu1103) starting from similar dilution rates. Fig. 9 depicts the result of formalde-
hyde metabolism analysis for Bacillus species. While iMZ1055 and iBsu1103 show co-metabolism of glucose/
formaldehyde as these GEMs contain pathways for assimilation of formaldehyde as a carbon source. However, 
iJA1121 was able to predict formaldehyde sensitivity in B. megaterium. From iJA1121 predictions, by increasing 
the formaldehyde uptake flux, the biomass production rate remained constant.
Metabolic flux analysis using [U-13c] glucose. Results of FBA simulations typically do not reflect the 
exact metabolic behavior due to the existence of multiple optimal solutions45. In other words, alternate optimal 
solutions are independent flux distributions that optimize the objective function due to the existence of alterna-
tive biochemical pathways46,47. Using FVA (Flux Variability Analysis), one can predict the possible range of each 
flux under a certain optimal growth condition. Therefore, we ran four FVA simulations to investigate how the 
simulated fluxes agree with experimentally-measured 13C flux data37. The results are shown in Fig. 10.
In the simulations, it was assumed that glucose is taken up by B. megaterium directly, as isotopic measure-
ments could not identify which glucose uptake pathway was active47. When comparing in silico results with exper-
imental data, suboptimal FVA is more relevant, as it allows the objective function to be within an allowable range 
(e.g., ≥90% of maximum biomass production rate)48.Suboptimal FVA simulations were performed by setting the 
biomass producing reaction to 90% of the maximal value obtained by FBA. In Table 3 the reactions are listed. 
As can be seen in Fig. 10, predictions are in good agreement with experimental data and 13C fluxes generally fall 
within the intervals suggested by FVA.
There are several possible glucose assimilation mechanisms defined in the model. The predicted interval for 
the conversion of glucose to glucose-6-phosphate which is limited to [0, 100] confirms the existence of alternative 
reactions for assimilation of glucose. In the predictions, there are some intervals where their maximal or min-
imal values are found to be unbound. This pertains, for example, to the conversion of glucose-6-phosphate to 
fructose-6-phosphate, PEP to pyruvate, pyruvate to acetyl-CoA, pyruvate to malate to oxaloacetate. The appear-
ance of these conditions is presumably related to the existence of futile cycles that are often inevitable in recon-
structing a GEM. Such futile cycles linked by malate dehydrogenase, pyruvate carboxylase, and the malic enzyme 
Figure 8. (a) Schematic of the shikimate production pathway. (b) Growth behavior analysis for aroK knock out 
mutant on different carbon sources. Pearson correlation coefficients and the -log(p-value) represent the results 
of the comparison study between in silico results and experimental data. The dashed line indicates the minimum 
−log(p-value) which was obtained for starch uptake. (c) Shikimate production simulations for aroK knock out 
mutant under different carbon sources.
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were investigated experimentally37. The occurrence of futile cycles enhances the versatility of the organism to 
survive in a changing environment. Futile cycles could act as alternative pathways in order to regulate the cellular 
metabolism of the organism to function optimally49. Overall, there is an acceptable agreement between the in 
silico results and the 13C labeling experiments (for more information see Fig. S2 in Supplementary Information).
Effect of carbon sources on fatty acid biosynthesis and lipid accumulation in B. megaterium. 
Acetyl-CoA as the precursor of fatty acids plays an important role in the metabolic network (see Fig. 11b). In 
cellular metabolism, a fraction of pyruvate is converted to acetyl-CoA, which is the main precursor for fatty acids 
and biosynthesis of lipids50. Acetyl-CoA carboxylase catalyzes the conversion of acetyl-CoA to malonyl-CoA. 
The next metabolic step, transfer of malonyl-CoA to malonyl-[acyl-carrier-protein (ACP)] is catalyzed by 
[ACP]-S-malonyl transferase, and this initiates the synthesis of fatty acids. Then, malonyl-ACP reacts either with 
an acetyl-CoA for imitation, or with acyl-CoA primers for elongation, resulting in ketoacyl-ACPs, leading to a 
process known as the elongation cycle. The elongation cycle includes two NADPH-dependent reduction steps 
accompanying by a dehydratase reaction51.
We investigated the effect of using different carbon sources on fatty acid biosynthesis and lipid accumula-
tion by comparing turnover rates of metabolites in the metabolic network. To do so, a flux-sum analysis was 
performed52. We compared the flux-sum values of metabolites in the network and the results are illustrated in 
Fig. 11. Four commonly used carbon sources reported in the literature (glucose, glycerol, sucrose, and xylose), 
were selected to run the simulations. The uptake flux rate of each carbon source was limited to 1 (mmol car-
bon)/gBM/h as the basis. Then, the flux-sum of the metabolites was calculated, as explained in the Materials and 
Figure 9. Results of formaldehyde sensitivity simulations in B. megaterium and B. subtilis using iJA1121, 
iMZ1055, and iBSU1103. For the simulations, formaldehyde flux was raised in a step-wise manner.
Figure 10. Comparison of FVA and suboptimal FVA simulations as well as 13C labeling experiments. Values in 
the figure are normalized with respect to the extracellular glucose uptake flux in percent. For a specific reaction, 
black values are the experimental 13C fluxes, blue values are the flux ranges obtained by FVA simulation and 
green values are intervals related to the suboptimal FVA simulation.
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Methods section. Fig. 11a illustrates the flux-sum results for the metabolites, normalized with the maximum value 
of each metabolite. Although most of the metabolites show similar levels for different carbon sources, glycerol 
has a higher flux-sum distribution and xylose represents the lowest flux-sum values for most of the compounds. 
The higher the utilization of central metabolism, the higher the production of the biomass precursors. Glycerol 
with high flux-sum values for amino acids and glycolytic intermediates could potentially be a favorite source for 
fermentation products such as poly-hydroxybutyrate53 and fatty acids54,55. High turnover rates of amino acids 
known to be the sources of acyl-CoAs (leucine, isoleucine, and valine) indicate active biosynthesis of fatty acids56. 
Besides, growth on glycerol exhibited the highest flux-sum value for acetyl-CoA, which in turn favors lipid 
accumulation. These findings prompted us to compare the flux-sum values of lipids (Fig. 11c,d). The maximum 
flux-sum values of lipids and fatty acid intermediates (specified with red boxes in the figures) were applied as the 
references for normalization. As shown in Fig. 11c, the flux-sum distribution indicates that lipids have compa-
rable flux-sums. It also shows that using glycerol as the carbon source leads to the highest flux-sum values for 
lipids. In addition, flux-sum values of fatty acids when glycerol is set as the carbon source are maximal (Fig. 11d). 
Among different types of fatty acids, C15-fatty acid had the highest, while C14- and C17-fatty acids had the lowest 
flux-sum values. These findings are consistent with the results reported by Scandella and Kornberg57 obtained 
during log-phase growth.
Materials and Methods
Genome files and genome-scale metabolic models. In order to identify the homologous gene pairs, 
GenBank genome (.gbk) files for B. m. DSM319, B. m WSH002, B. subtilis 168 (B. s. 168) and B. licheniformis 
WX02 (B. l. WX02) containing genomic sequences and annotations were downloaded (with accession num-
bers CP001982.1, CP003017.1, CP010052.1, and AHIF00000000.1, respectively). Four GEMs, iMZ1055 for B. m 
WSH00228, iBsu114758 and iBsu110359 for B. subtilis 168 and iWX1009 for B. licheniformis. WX0260 were obtained 
for comparison and/or were used as the reconstruction templates.
Genome-scale metabolic network reconstruction. As the first step, a homology search was done based 
on progressive multiple alignments using Mauve version 2.4.0, using its default parameter settings. Mauve is a 
computational framework for multiple genome alignments in the presence of large-scale evolutionary events30. 
Accordingly, the related GenBank genome files containing genomic sequences and annotations were downloaded 
to identify gene orthologous pairs using the ‘progressiveMauve’ tool. Then, based on the results gained by Mauve, 
the associated reactions in iMZ1055 were identified and used as the basis of the draft network. In the second 
step, the refinement of the draft network was automatically performed (and then manually curated) based on 
public biochemical databases such as KEGG61, MetaCyc62, UniProt63, and PATRIC64. In the next step, with a sim-
ilar strategy, we found all of the relevant genes and reactions which were present in iBsu110359, iBsu114758 and 
iWX100960 and their corresponding GenBank genome files. Then, according to the information on TCDB65, the 
transport equations were added to the draft network. Finally, the gaps of the model were identified and corrected, 
based on the phenotyping results as well as the experimental data reported in the literature.
flux balance analysis and biomass objective function. FBA is one of the popular methods for analyz-
ing the flux of reactions in metabolic networks under steady-state conditions66,67. FBA assumes that no accumula-
tion of metabolites occurs during growth (dc/dt = 0), while a cellular objective, typically biomass production rate, 
is optimized. Based on the FBA, a linear programming problem is defined as follows:
No. Reaction
Does the experimental value fall 
within the predicted interval?
1 G6P[c] ↔ F6P[c] Yes
2 ATP[c] + GLC[c] → H[c] + ADP[c] + G6P[c] Yes
3 2PG[c] ↔ H2O[c] + PEP[c] Yes
4 H[c] + ADP[c] + PEP[c] → PYR[c] + ATP[c] Yes
5 E4P[c] + XUL5P[c] ↔ T3P1[c] + F6P[c] Yes
6 T3P1[c] + S7P[c] ↔ E4P[c] + F6P[c] Yes
7 2PG[c] ↔ 3PG[c] Yes
8 FDP[c] ↔ T3P2[c] + T3P1[c] Yes
9 XUL5P[c] + R5P[c] ↔ T3P1[c] + S7P[c] Yes
10 2 OFER[c] + PYR[c] + COA[c] → 2 RFER[c] + ACCOA[c] + CO2[c] + 2 H[c] Yes
11 ATP[c] + AC[c] + COA[c] ↔ ADP[c] + ACCOA[c] + PI[c] Yes
12 PYR[c] + ATP[c] + HCO3[c] → H[c] + OA[c] + ADP[c] + PI[c] No
13 H2O[c] + OA[c] + ACCOA[c] ↔ H[c] + COA[c] + CIT[c] Yes
14 H2O[c] + FUM[c] ↔ MAL[c] Yes
15 NAD[c] + MAL[c] → PYR[c] + NADH[c] + CO2[c] Yes
16 ATP[c] + OA[c] → CO2[c] + ADP[c] + PEP[c] Yes
Table 3. Metabolic reactions used to carry out the FVA simulations.
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where Z is a linear function related to the cellular objective and the coefficients cj determine the weights of the 
reaction j. Also, vj refers to the flux rate of the reaction j in the network and Sij is the stoichiometric coefficient 
of metabolite i in reaction j. In this approach, each flux, vi, is constrained to the given minimum and maximum 
values. To perform FBA, a biomass producing reaction, representing a weighted ratio of components in cell dry 
weight, is maximized based on the evolutionary assumption68,69. In this study, the biomass producing reaction of 
the iMZ1055 model is used, which in turn is based on the biomass composition of the B. subtilis model70. Unless 
stated otherwise, the biomass production rate was used as the objective function in FBA simulations.
flux variability analysis. FVA is a mathematical tool for finding the minimum and maximum possible 
fluxes of each reaction, while other constraints are satisfied and the objective function takes the optimal (or, sub-
optimal) value71. In this study, suboptimal FVA was used to find the minimum and maximum possible fluxes of 
each reaction while the objective function was bound to 90% of its maximal value (achieved by FBA).
flux-sum analysis. In order to illuminate the role of metabolite in the network and study turnover rates 
of the metabolites, we used flux-sum analysis72. The flux-sum of metabolite i is defined as the summation of all 
consumption or generation fluxes as follows52:
∑ϕ = S v12i j ij j
The existence of possible alternate optimal solutions can result in ambiguity in the interpretation of FBA solu-
tions. Thus, to identify the most plausible flux distribution, the minimization of the sum of total fluxes makes the 
calculation ϕi feasible73.
experimental methods. To discern the phenotypic pattern of B. m. DSM319, the ability of the strain to 
grow on different carbon sources was tested using the Biolog GEN III microplate. This was used to analyze the 
strain under 94 phenotyping tests. As specified by the manufacturer, a pure culture of the strain was incubated 
at 30 °C overnight on an agar plate with 5% sheep blood, and then suspended in a special inoculating fluid at 
the predetermined cell density (90–98% Transmittance). Then, 100 ml of the cell suspension was inoculated 
Figure 11. The heatmap representing the results of the flux-sum values of different components including 
glycolytic intermediates, TCA cycle intermediates, amino acids, and lipids. The comparisons were conducted for 
different carbon sources. (b) Schematic of fatty acid biosynthesis pathway. (c) Results of flux-sum values of the 
lipids constituting biomass. (d) Results of flux-sum values of the lipids constituting biomass.
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into each well of the GEN III MicroPlate™. The microplate was incubated at 30 °C for 24 hours. Readouts of 
growth-dependent color change were obtained using a microplate reader and interpreted based on the Biolog 
protocols.
conclusion
Aerobic Gram-positive Bacillus species are commonly used in biotechnology, especially in food, pharmaceutical, 
and environmental processes. Lack of knowledge about growth behavior of these organisms complicates the 
design and monitoring of industrial microbial processes. Generating constraint-based models that can predict 
growth behavior is an important step in addressing this knowledge gap. In this regard, several GEMs for Bacillus 
species have been constructed. After the reconstruction of the GEM for B. subtilis 168, generated by Oh et al., in 
silico models were developed for B. m. WSH002 (iMZ1055) and B. l. WX02 (iWX1009). In addition, two other 
GEMs for B. subtilis 168, iBsu1103 and iBsu1147, were published more recently. It has been reported that existing 
genome-scale models for B. megaterium could not correctly predict the utilization of amino acids and some car-
bon sources29. Herein, we present a GEM for B. m. DSM319, iJA1121. The model includes 1709 reactions, 1349 
metabolites with 1121 genes. Barring exchange reactions, 91% of the reactions are gene-associated.
Following an automated approach, the draft network was curated manually by updating the GPR associ-
ations and EC numbers as well as adding several reactions. The genome-scale model was validated using our 
own experimental data on Biolog phenotyping and published data on B. m. DSM319 growth on different carbon 
sources (available on PubMed). FBA and FVA were applied to perform the simulations. Our findings suggested a 
better agreement of in silico predictions and experimental data for iJA1121. Results of carbon source utilization 
experiments and the model predictions matched in 96% cases. Moreover, the growth behavior of different mutant 
strains of B. m. DSM319 was studied and results indicated a very good match between iJA1121 predictions and 
in vivo data, with very few exceptions. For instance, the simulation of shikimate production in aroK knock out 
worked well on all tested carbon sources except sucrose. Further investigations were performed by comparing in 
silico results with 13C labeling experiments. Regarding suboptimal FVA results, the experimental 13C fluxes fell 
within the predicted intervals. In conclusion, iJA1121 seems to offer a clear improvement over iMZ1055, where 
the success rate of the previous model in accurately predicting growth behavior in the same type of simulations 
was only 70%.
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